Back to Trades
Skinner Jann Elizabeth
DirectorCIK 0002121838
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Across 1 filing between 2026, Skinner Jann Elizabeth, Director, has disclosed $0 in transactions — all concentrated in Telix Pharmaceuticals Ltd (TLX). Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
1 loaded
| Mar 18 | TLX Telix Pharmaceuticals Ltd | Skinner Jann Elizabeth | Director | Other | $0 |
1 filing